Jacek Tomaszewski
Medical University of Lublin
Network
Latest external collaboration on country level. Dive into details by clicking on the dots.
Publication
Featured researches published by Jacek Tomaszewski.
International Urogynecology Journal | 2003
Tomasz Rechberger; Katarzyna Rzeźniczuk; Paweł Skorupski; Aneta Adamiak; Jacek Tomaszewski; Włodzimierz Baranowski; Jerzy A. Jakowicki
Our objective was to compare monofilament and multifilament tapes positioned without tension at the midurethra for postoperative complications and cure rate. One hundred patients with stress urinary incontinence were randomly allocated into two study groups. Using identical surgical methodology, 50 patients had a monofilament tape inserted at the midurethra using the TVT delivery instrument, and another 50 a multifilament tape using the IVS delivery instrument. The only significant difference between the groups was in the incidence of postoperative urinary retention (p=0.023). Ten patients from the monofilament group required longer than normal (‘normal’ means to the morning of the next day) catheterization, in contrast to only two from the multifilament group. The clinical efficacy of both procedures was equally high. Conclusions were that both tapes appear to be equally effective in the surgical treatment of SUI. The higher incidence of postoperative urinary retention in the monofilament group was most likely caused by the elastic feature of this tape.
Pathology Research and Practice | 2000
Andrzej Semczuk; Regine Schneider-Stock; Roman Miturski; Danuta Skomra; Jacek Tomaszewski; Albert Roessner; Jerzy A. Jakowicki
The aim of the current study was to investigate the immunohistochemical expression of the retinoblastoma protein (pRB) in formalin-fixed, paraffin-embedded specimens obtained from 62 patients suffering from endometrial cancer. The avidin-biotin-peroxidase detection system with microwave pretreatment and the mouse anti-human NCL-RB1 monoclonal antibody were used. Heterogeneous nuclear immunostaining for the pRB was generally observed in the glandular cells in 59 out of 62 (95%) endometrial carcinomas, while stromal components were unreactive. In one case of stage Ic endometrioid adenocarcinoma, a small percentage of glandular cells (5%) stained positively with the anti-RB antibody, while two other tumors (stage IIa adenosquamous carcinoma and stage IIIa endometrioid adenocarcinoma) were pRB negative. In the cases with concomitant hyperplastic and neoplastic endometrial lesions, pRB immunoreaction was heterogeneous in the hyperplastic endometrial cells and in the adjacent neoplastic endometrium. Moreover, eight cases of endometrial carcinoma harboring K-ras codon 12 gene point mutation overexpressed pRB (more than 80% of glandular endometrial cells were positive) immunohistochemically, while none of three pRB negative slides had a K-ras gene alteration. Our data support the view that the pRB is expressed in most of the human endometrial neoplasms, but the lack of pRB immunoreactivity may correspond with the retinoblastoma gene rearrangements in a subset of advanced endometrial carcinomas.
The Journal of Urology | 2011
Tomasz Rechberger; Konrad Futyma; Katarzyna Jankiewicz; Aneta Adamiak; Michał Bogusiewicz; Aleksandra Bartuzi; Paweł Miotła; Paweł Skorupski; Jacek Tomaszewski
PURPOSE Mid urethral slings are effective surgical treatment for stress urinary incontinence. However, 5% to 20% of patients still experience surgical failure with clinically significant recurrent or persistent stress urinary incontinence. Since a subset of these failures may be caused by improper tape position, we elucidated whether additional paraurethral fixation of a tape to prevent displacement during tensioning could improve the transobturator sling outcome. MATERIALS AND METHODS The study was done in 463 patients with stress urinary incontinence who were randomly allocated to treatment with a standard transobturator intravaginal monofilament sling procedure (232) or to an intravaginal transobturator monofilament sling with additional 2-point tape fixation (231). Another 2 absorbable sutures parallel to the urethra were added to fix the tape and prevent displacement during tape tensioning. Outcome was assessed by a cough test and a 1-hour pad test at 12 months. RESULTS Clinical efficacy of the procedure with fixation was significantly higher with 195 women (95.12%) cured or improved compared to the 199 (88.73%) cured or improved with the standard sling (chi-square 5.71, p = 0.0169). There was no increase in intraoperative or postoperative complications. Also, among patients with intrinsic sphincter deficiency we noted a significantly better outcome in the fixation group than in the control group, that is 39 of 41 patients (95.1%) cured or improved vs 31 of 42 (73.8%) (chi-square 10.65, p = 0.0011). CONCLUSIONS Tape fixation significantly increases the clinical efficacy of the transobturator sling, especially in patients with intrinsic sphincter deficiency.
European Journal of Obstetrics & Gynecology and Reproductive Biology | 1999
Tomasz Rechberger; Włodzimierz Baranowski; Krzysztof Postawski; Artur J. Jakimiuk; Jacek Tomaszewski; Beata Kulik-Rechberger; Jerzy A. Jakowicki
OBJECTIVES To investigate serum leptin concentrations in women taking oral contraceptives containing the same gestagen and different doses of ethinyl estradiol. STUDY DESIGN 30 women received tablets containing 20 microg of ethinyl estradiol (EE) and 150 microg of desogestrel (DSG) (Mercilon) whereas another group of 30 women received 30 microg of EE and 150 microg of DSG (Marvelon). Serum leptin concentrations were estimated using a Leptin RIA kit (Linco Research USA) after an overnight fast on the first day of the cycle prior to the onset of therapy as well as after the 3rd and 6th treated cycles. RESULTS In both groups a positive correlation between serum leptin and body mass index (BMI) was found (r=0.56; P<0.001 and r=0.67; P<0.001). The initial serum leptin concentration in the Mercilon group was 7.62+/-8.46 ng/ml. This value was not statistically different from values after 3 months (9.31 8.23 ng/ml) and after 6 months (10.53+/-8.03 ng/ml) of treatment. Very similar results were found in patients receiving Marvelon: 8.81+/-6.56 ng/ml initially; 11.62+/-11.16 ng/ml at 3 months, and 10.38+/-7.32 ng/ml at 6 months. The statistical analysis did not reveal any significant difference at each investigated time point in either study group. CONCLUSIONS Modern low dose OC containing third generation gestagen and low dose of ethinyl estradiol, does not have any influence on serum leptin or BMI, and therefore does not exert a significant influence on body energy metabolism.
Ginekologia Polska | 1998
Jacek Tomaszewski; Miturski R; Andrzej Semczuk; Jan Kotarski; Jerzy A. Jakowicki
Ginekologia Polska | 2003
Jacek Tomaszewski; Aneta Adamiak; Paweł Skorupski; Wojciech Rzeski; Tomasz Rechberger
International Braz J Urol | 2011
Tomasz Rechberger; Konrad Futyma; Katarzyna Jankiewicz; Aneta Adamiak; Michał Bogusiewicz; A Bartuzi; P MiŁota; Paweł Skorupski; Jacek Tomaszewski
Contraception | 2004
Tomasz Rechberger; Jacek Tomaszewski; Anna Pieprzowska-Białek; Beata Kulik-Rechberger; Paweł Skorupski
European Journal of Obstetrics & Gynecology and Reproductive Biology | 2006
Michał Bogusiewicz; Andrzej Wróbel; Katarzyna Jankiewicz; Aneta Adamiak; Paweł Skorupski; Jacek Tomaszewski; Tomasz Rechberger
Ginekologia Polska | 2003
Tomasz Rechberger; Andrzej Wróbel; Aneta Adamiak; Skomra D; Korobowicz E; Jacek Tomaszewski; Czuczwar M; Paweł Skorupski